JBCHEPHARM

J.B. Chemicals & Pharmaceuticals Ltd.

· Pharma & Health
₹ CrorePeersTORNTPHARMALKEMIPCALABSAILIFENHNEULANDLABACUTAASNATCOPHARM
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation138.3171.0182.5
+ Finance Costs44.311.75.6
+ Interest Income-4.4-5.3-33.8
+ Dividend Income0.0-0.00.0
+ Fair Value (Gains) / Losses-16.6-5.4-10.7
+ Share-based Payments42.054.971.0
+ Unrealised FX (Gain) / Loss-10.65.620.1
+ Other Non-cash Items10.13.018.9
Changes in Working Capital
+ Inventories-72.0-26.4-154.5
+ Trade Receivables — Current-71.6-49.8-56.6
+ Other Current Assets-16.1-26.8-14.5
+ Other Non-current Assets0.2-0.20.0
+ Trade Payables — Current138.083.4-20.3
Cash from Operating Activities
Profit Before Tax (per I/S)751.5887.4952.3
+ Total Adjustments (incl. Working Capital)181.6215.77.9
Cash from Operations (pre-tax)933.11,103.1960.2
+ Income Taxes Paid132.5200.7256.3
Cash from Operating Activities800.6902.5703.9
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)126.997.60.0
+ Acq of Intangible Assets134.522.70.0
+ Disp of Fixed Assets1.01.10.0
+ Acq of Goodwill0.00.0-1.9
+ Disp of Biological Assets0.00.0-83.2
+ Dividends Received — Investing0.00.00.0
+ Interest Received — Investing4.14.59.8
+ Other Inflows / (Outflows) — Investing-147.5-181.3-514.3
Cash from Investing Activities-403.8-295.9-585.9
Cash from Financing Activities
+ Proceeds from Exercise of Stock Options20.024.0232.0
+ Repayment of Borrowings191.6343.913.8
+ Payment of Lease Liabilities0.013.124.9
+ Payment of Finance Lease Liabilities12.7
+ Interest Paid44.29.63.1
+ Dividends Paid157.0237.0313.3
Cash from Financing Activities-385.5-579.7-123.1
Net Changes in Cash (pre-FX)11.326.9-5.1
+ Effect of FX Rate Changes on Cash-0.0-0.00.2
Net Changes in Cash11.326.9-4.9
Closing Cash88.2
Reference Items
EBITDA896.91,031.81,107.4
EBITDA Margin %25.7426.3426.70
Free Cash Flow (CFO − Capex)539.3782.2703.9
Free Cash Flow to Equity429.2687.1
Free Cash Flow per Basic Share33.5848.7043.83
Cash Flow to Net Income1.451.370.99
Cash Paid for Taxes132.5200.7256.3
Cash Paid for Interest44.29.63.1
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.